- Home
- VNOM vs TMDX Comparison
VNOM vs TMDX Comparison
Compare VNOM & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNOM
- TMDX
- Stock Information
- Founded
- VNOM 2013
- TMDX 1998
- Country
- VNOM United States
- TMDX United States
- Employees
- VNOM N/A
- TMDX N/A
- Industry
- VNOM Oil & Gas Production
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- VNOM Energy
- TMDX Health Care
- Exchange
- VNOM Nasdaq
- TMDX Nasdaq
- Market Cap
- VNOM 4.9B
- TMDX 4.8B
- IPO Year
- VNOM 2014
- TMDX 2019
- Fundamental
- Price
- VNOM $37.10
- TMDX $115.68
- Analyst Decision
- VNOM Strong Buy
- TMDX Buy
- Analyst Count
- VNOM 13
- TMDX 9
- Target Price
- VNOM $56.85
- TMDX $129.88
- AVG Volume (30 Days)
- VNOM 1.8M
- TMDX 909.2K
- Earning Date
- VNOM 08-04-2025
- TMDX 07-30-2025
- Dividend Yield
- VNOM 6.64%
- TMDX N/A
- EPS Growth
- VNOM 42.93
- TMDX N/A
- EPS
- VNOM 3.82
- TMDX 1.41
- Revenue
- VNOM $854,200,000.00
- TMDX $488,227,000.00
- Revenue This Year
- VNOM $60.92
- TMDX $34.07
- Revenue Next Year
- VNOM $33.92
- TMDX $20.76
- P/E Ratio
- VNOM $9.73
- TMDX $82.00
- Revenue Growth
- VNOM 2.52
- TMDX 64.43
- 52 Week Low
- VNOM $34.71
- TMDX $55.00
- 52 Week High
- VNOM $56.76
- TMDX $177.37
- Technical
- Relative Strength Index (RSI)
- VNOM 40.61
- TMDX 38.66
- Support Level
- VNOM $36.43
- TMDX $109.59
- Resistance Level
- VNOM $38.90
- TMDX $127.97
- Average True Range (ATR)
- VNOM 1.12
- TMDX 5.57
- MACD
- VNOM -0.04
- TMDX -2.35
- Stochastic Oscillator
- VNOM 31.08
- TMDX 22.52
About VNOM Viper Energy Inc.
Viper Energy Inc is focused on owning and acquiring mineral and royalty interests in oil and natural gas properties primarily in the Permian Basin. The Permian Basin is known to have a number of zones of oil and natural gas-bearing rock throughout.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.